HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

1-Ethynyl-1-hydroxy-11a-methyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta(a)phenanthren-7-one

HCID 4536
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
68-22-4
Standard SMILES
C#CC1(O)CCC2C3CCC4=CC(=O)CCC4C3CCC21C
InChIKey
VIKNJXKGJWUCNN-UHFFFAOYSA-N
Molecular formula
C20H26O2
Average molar mass
298.4 g/mol
Monoisotopic mass
298.19328007

Overview

See also: Norethindrone (annotation moved to).

Names & identifiers

Preferred name
1-Ethynyl-1-hydroxy-11a-methyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta(a)phenanthren-7-one
IUPAC
17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
English name
Norethindrone
Molecular formula
C20H26O2
Molecular weight
298.43

Names & synonyms

DTXSID60859071RefChem:1055472DTXCID502087911-Ethynyl-1-hydroxy-11a-methyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta(a)phenanthren-7-one17-Ethynyl-17-hydroxyestr-4-en-3-one(17beta)-17-ethynyl-17-hydroxyestr-4-en-3-one17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one17.alpha.-Ethinyl-19-nortestosterone17.alpha.-Ethynyl-19-nortestosterone19-Nor-17.alpha.-ethynyltestosterone17.alpha.-Ethynyl-4-estren-17-ol-3-one17.alpha.-Ethynyl-17-hydroxy-4-estren-3-one
Show more names
NORETHISTERONENETENTNorethindrone (Norethisterone)19-NORETHINDRONEElkCek6ElkhHek6EPB1
17.alpha.-Ethinylestra-4-en-17.beta.-ol-3-one17.beta.-Hydroxy-19-norpregn-4-en-20-yn-3-oneEstr-4-en-3-one, 17.alpha.-ethynyl-17-hydroxy-17.alpha.-Ethynyl-17.beta.-hydroxyestr-4-en-3-one17-Hydroxy-19-nor-17.alpha.-pregn-4-en-20-yn-3-one19-nor-17.alpha.-Ethynylandrosten-17.beta.-ol-3-one17.alpha.-Ethynyl-19-nor-4-androsten-17.beta.-ol-3-one17.alpha.-Ethynyl-19-norandrost-4-en-17.beta.-ol-3-one

Properties

Computed structural properties

XLogP
3
Topological polar surface area
37.3 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
2
Rotatable bonds
1
Heavy atoms
22
Formal charge
0
Complexity
594

Experimental & physicochemical properties

DrugsPharmaceuticals

Physicochemical properties

Melting point
205 · 205-206 °C (lit.)
Boiling point
379.83 °C · 379.83°C (rough estimate)
alpha
20 · D20 -31.7° (chloroform); D20 -25° (chloroform)
Density
1.0766 · 1.0766 (rough estimate)
refractive index
1.48 · 1.4800 (estimate)
storage temp.
2 · 2-8°C
solubility
50 mg/mL, · chloroform: ≥50 mg/mL, clear, colorless
form
powder
pka
13.09 · 13.09±0.40(Predicted)
color
white to off-white
biological source
rabbit
Water Solubility
7.043 mg/L · 7.043mg/L(25 ºC)
Merck

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Safety data

wgk
3
rtecs
RC8975000
ridadr
UN 3077 9 / PGIII
hs_code
29144000
Toxicity
LD50 oral in mouse: 6gm/kg
risk_code
40-36/37/38-20/21/22
Signal word
Danger
Symbol(GHS)
GHS08,GHS09
hazard_code
Xn
safety_code
22-36/37/39-45-37/39-26
Storage Class
6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
Hazard statements
H351-H360FD-H362-H410
REACH Registrations
Active
Hazard Classifications
Aquatic Acute 1Aquatic Chronic 1Carc. 2Lact.Repr. 1A
Precautionary statements
P202-P260-P263-P264-P273-P308+P313
Hazardous Substances Data
68-22-4(Hazardous Substances Data)

Chemistry & industry

Applications · 7 items

DescriptionNorethindrone is a progestin (a synthetic substance with properties similar to progesterone) that is best known as the first female oral contraceptive, or the “pill.”Norethindrone’s global impact on society and culture has made it one of the most important inventions in history.

HistoryThe development of norethindrone as a female oral contraceptive took place indirectly over 30 years as a result of steroid research.This research accelerated in the 1930s when structures and medical applications of steroidal compounds were determined.Steroids are lipids, which include cholesterol, bile salts,and sex hormones,that are characterized by a structure of three fused six-carbon rings and a five-carbon ring. In 1957, both norethindrone and norethynodrel were approved by the Food and Drug Administration (FDA) for treating menstrual problems and infertility. In 1960, the FDA approved Searle's norethynodrel under the trade name Enovid. Norethindrone was approved as an oral contraceptive in 1962 under the trade name Ortho-Novum.

UsesProgestin contraceptives work by producing pregnant-like conditions in a female to preventovulation.During pregnancy, progesterone is released by the placenta during development ofthe fetus.This in turn suppresses development of egg follicles and ovulation. Progestins mimicthis condition and thus prevent or delay ovulation.Oral contraceptives currently use progestinand estrogen in combination to prevent ovulation and thicken cervical mucus.The latter makeit harder for sperm to enter the uterus and for an egg to implant on the uterine wall.

Usesprogestogen

UsesA synthetic progestin

UsesProgesteron. Norethindrone and acetate in combination with estrogen as contraceptive (oral). It is reasonably anticipated to be a human carcinogen

General DescriptionNorethindrone, 17α-ethinyl-19-nortestosterone, and itsΔ5(10)-isomer, norethynodrel, might appear at first glance tobe subtle copies of each other. One would predict that theΔ5(10)-double bond would isomerize in the stomach’s acid tothe Δ4-position. However, the two drugs were actually developedsimultaneously and independently; hence, neither can beconsidered a copy of the other. Furthermore, norethindrone isabout 10 times more active than norethynodrel, indicating that isomerization is not as facile in vivo asone might predict. Although they are less active than progesteronewhen given subcutaneously, they have the importantadvantage of being orally active. The discovery of the potentprogestin activity of 17α-ethinyltestosterone (ethisterone) and19-norprogesterone preceded the development of these potentprogestins. Both are orally active, with the 17α-ethinyl groupblocking oxidation to the less active 17-one. The rich electrondensity of the ethinyl group and the absence of the 19-methylgroup greatly enhance progestin activity. Both compoundswere of great importance as progestin components of oralcontraceptives, although currently, use of norethynodrel isminimal. Norethindrone, USP, and norethindrone acetate,USP, are widely used for all the usual indications of the progestins,as well as being components of oral contraceptives.Because these compounds retain key features of the testosteronestructure, including the 17β-OH, it is not surprisingthat they possess some androgenic side effects.

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes

Database identifiers

CAS
68-22-4
PubChem CID
4536
DTXSID
DTXSID60859071
ChEMBL
CHEMBL4579631
6697 · 6697
BRN
1915671 · 1915671
Specific Activity
122 · 122-165nmol/min·mg
Henry's Law Constant
1.7 · 1.7×104 mol/(m3Pa) at 25℃, HSDB (2015)
BCS Class
1 · 1
Major Application
pharmaceutical (small molecule)
InChI
1S/C20H26O2/c1-3-20(22)11-9-18-17-6-4-13-12-14(21)5-7-15(13)16(17)8-10-19(18,20)2/h1,12,15-18,22H,4-11H2,2H3/t15-,16+,17+,18-,19-,20-/m0/s1
InChIKey
VIKNJXKGJWUCNN-XGXHKTLJSA-N
SMILES
O[C@@]1([C@@]2([C@H]([C@H]3[C@@H]([C@H]4CCC(=O)C=C4CC3)CC2)CC1)C)C#C
CAS DataBase Reference
68 · 68-22-4(CAS DataBase Reference)
FDA UNII
18 F433X4S · T18F433X4S
Proposition 65 List
Norethisterone (Norethindrone)
NCI Drug Dictionary
Norlutate
ATC code
3 AC01,G03DC02 · G03AC01,G03DC02
NIST Chemistry Reference
Norethindrone(68-22-4)
EPA Substance Registry System
Norethisterone (68-22-4)
UNSPSC Code
41116107 · 41116107
NACRES
77 · NA.77
Protein binding
60 % · 60%
Excreted unchanged in urine
50 · 50-80 (as metabolites)
Volume of distribution
3.1 · 3.1-5.7(L/kg)
Biological half-life
5 · 5 / -
Symbol(GHS)
8 · GHS08,GHS09
Signal word
Danger
Hazard statements
351 · H351-H360FD-H362-H410
Precautionary statements
202 · P202-P260-P263-P264-P273-P308+P313
Hazard Codes
Xn
Risk Statements
40 · 40-36/37/38-20/21/22
Safety Statements
22 · 22-36/37/39-45-37/39-26
RIDADR
3077 · UN 3077 9 / PGIII
WGK Germany
3 · 3
RTECS
8975000 · RC8975000
HS Code
29144000 · 29144000
Storage Class
6.1 C · 6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
Hazard Classifications
1 Aquatic · Aquatic Acute 1Aquatic Chronic 1Carc. 2Lact.Repr. 1A
Hazardous Substances Data
68 · 68-22-4(Hazardous Substances Data)
Toxicity
50 oral · LD50 oral in mouse: 6gm/kg
REACH Registrations
Active

Upstream & downstream products

Upstream raw materials

TetrahydrofuranAmmoniaLithium ion (1+)PotassiumAcetyleneChromic acidTriethyl orthoformateEstrone 3-methyl etherNorandrostenedione19-Aldoandrostenedione3-Ethoxyestra-3,5-dien-17-one3-methoxyestra-2,5(10)-dien-17beta-ol19-Norpregna-2,5(10)-dien-20-yn-17-ol, 3-methoxy-, (17α)- (9CI)19-Hydroxy-4-androstene-3,17-dione19-Carboxyandrost-4-ene-3,17-dioneNorethindrone-3-ethyldienoletherNandrolone

Downstream products

19-Nor-17-alpha-pregna-3,5-dien-20-yne-3,17-diol, diacetate

Additional notes

DefinitionChEBI: A 17beta-hydroxy steroid that is testosterone in which the hydrogen at position 17 is replaced by an ethynyl group and in which the methyl group attached to position 10 is replaced by hydrogen.